CIK 0001661181 · Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-16 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −317 | $3.09 | $980 | 139,766 |
| 2024-04-01 | Bilbo Patrick Chief Operating Officer | Shares withheld for taxes | −2,497 | $2.80 | $7K | 809,082 |
| 2024-04-01 | Freedman Lori Chief Admin. and Legal Officer | Shares withheld for taxes | −1,974 | $2.80 | $6K | 469,272 |
| 2024-04-01 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −1,977 | $2.80 | $6K | 520,809 |
| 2024-04-01 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −1,752 | $2.80 | $5K | 168,268 |
| 2024-04-01 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −10,113 | $2.80 | $28K | 2,351,949 |
| 2024-03-28 | Bilbo Patrick Chief Operating Officer | Option exercise | +152,250 | $1.18 | $180K | 811,579 |
| 2024-03-28 | Bilbo Patrick Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −152,250 | 0 | ||
| 2024-02-21 | Montecalvo Antonio S. Vice President, Health Policy | Grant or award | +43,732 | 170,020 | ||
| 2024-02-21 | Montecalvo Antonio S. Vice President, Health Policy | Grant or award · Stock Option (Right to Buy) | +79,068 | 79,068 | ||
| 2024-02-21 | Francisco David Chief Financial Officer | Grant or award | +160,350 | 428,996 | ||
| 2024-02-21 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +289,915 | 289,915 | ||
| 2024-02-21 | Grow Brian Chief Commercial Officer | Grant or award | +173,469 | 522,786 | ||
| 2024-02-21 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +313,636 | 313,636 | ||
| 2024-02-21 | Freedman Lori Chief Admin. and Legal Officer | Grant or award | +153,061 | 471,246 | ||
| 2024-02-21 | Freedman Lori Chief Admin. and Legal Officer | Grant or award · Stock Option (Right to Buy) | +276,737 | 276,737 | ||
| 2024-02-21 | Bilbo Patrick Chief Operating Officer | Grant or award | +187,318 | 659,329 | ||
| 2024-02-21 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +338,674 | 338,674 | ||
| 2024-02-21 | Gillheeney Gary S. President and CEO | Grant or award | +685,131 | 2,362,062 | ||
| 2024-02-21 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +1,238,729 | 1,238,729 |
Page 10 of 12 · 228 trades